MENU

ABOS Acumen Pharmaceuticals Forecast, Technical & Fundamental Analysis

Industry Biotechnology
ABOS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
ABOS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ABOS is expected to report earnings to fall 21.76% to -39 cents per share on March 31

Acumen Pharmaceuticals ABOS Stock Earnings Reports
Q4'24
Est.
$-0.39
Q3'24
Missed
by $0.14
Q2'24
Missed
by $0.07
Q1'24
Beat
by $0.01
Q4'23
Missed
by $0.11
The last earnings report on November 12 showed earnings per share of -50 cents, missing the estimate of -36 cents. With 104.09K shares outstanding, the current market capitalization sits at 161.01M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
427 Park Street
Phone
+1 434 297-1000
Employees
52
Web
https://www.acumenpharm.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AFDRX56.55-0.12
-0.21%
American Century Sustainable Equity R
CMRGX10.14-0.04
-0.39%
Calamos Merger Arbitrage I
CMIDX26.55-0.27
-1.01%
Congress Mid Cap Growth Retail
WILCX9.78-0.12
-1.21%
Wasatch Global Value Institutional
MCEIX12.96-0.28
-2.11%
Martin Currie Emerging Markets I

ABOS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with SNDX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then SNDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
-16.77%
SNDX - ABOS
50%
Loosely correlated
-25.55%
AURA - ABOS
49%
Loosely correlated
-4.40%
ABCL - ABOS
49%
Loosely correlated
-6.35%
MGTX - ABOS
48%
Loosely correlated
-6.20%
INZY - ABOS
48%
Loosely correlated
-6.00%
More